FDA hands a CRL to drug­mak­er Eton af­ter a de­layed in­spec­tion — but are Covid-19 trav­el re­stric­tions re­al­ly the is­sue?

For the sec­ond time in three years, Eton Phar­ma­ceu­ti­cals has re­ceived a com­plete re­sponse let­ter from the FDA, this time for its de­hy­drat­ed al­co­hol in­jec­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.